Vertex Pharmaceuticals Operating Margin Trend from 2010 to 2020

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 40px;;'>VRT</div>
VRTX -- USA Stock  

Fiscal Quarter End: March 31, 2020  

Vertex Pharmaceuticals Operating Margin yearly trend continues to be fairly stable with very little volatility. Operating Margin is likely outpace its year average in 2020. During the period from 2010 to 2020 Vertex Pharmaceuticals Operating Margin regression line of anual values had significance of 0.27 and arithmetic mean of (7.14). Vertex Pharmaceuticals Weighted Average Shares is fairly stable at the moment as compared to the last year. Vertex Pharmaceuticals reported Weighted Average Shares of 228.86 Million in 2019. Income Tax Expense is likely to grow to about 16.2 M in 2020, whereas Consolidated Income is likely to drop (104.3 M) in 2020. Check Vertex Pharmaceuticals fundamental indicators over time to gain insight into the company future performance. Apply historical fundamental analysis to find patters among financial statement drivers such as Direct Expenses of 397.7 M, Cost of Revenue of 204.4 M or Gross Profit of 1.2 B, as well as many exotic indicators such as Interest Coverage of 18.07, Long Term Debt to Equity of 0.1548 or PPandE Turnover of 4.57. This can be a perfect complement to check Vertex Pharmaceuticals Valuation or Volatility. It can also complement various Vertex Pharmaceuticals Technical models. Also please take a look at analysis of Vertex Pharmaceuticals Correlation with competitors.

Vertex Pharmaceuticals Operating Margin Marginal Breakdown

Showing smoothed Operating Margin of Vertex Pharmaceuticals Incorpor with missing and latest data points interpolated.


          10 Years Trend
Slightly volatile
 Operating Margin 

Vertex Pharmaceuticals Regression Statistics

Arithmetic Mean(7.14)
Coefficient Of Variation(457.03)
Mean Deviation 26.10
Median 4.95
Standard Deviation 32.64
Sample Variance 1,065
Range 99.55
R Value 0.36
Mean Square Error 1,027
R Squared 0.13
Significance 0.27
Slope 3.58
Total Sum of Squares 10,653

Vertex Pharmaceuticals Operating Margin Over Time

2018  20.84 
2019  18.76 
2020  25.01